The Challenges Faced in Developing Novel Drug Radiation Combinations in Non-small Cell Lung Cancer

S Harrow, G G Hanna, C Faivre-Finn, F McDonald, A J Chalmers

Research output: Contribution to journalArticle

4 Citations (Scopus)
261 Downloads (Pure)

Abstract

Lung cancer is the most common cancer diagnosed in the UK. Outcomes for patients with this disease remain poor and new strategies to treat this disease require investigation. One potential option is to combine novel agents with radiotherapy in clinical studies. Here we discuss some of the important issues to consider when combining novel agents with radiotherapy, together with potential solutions as discussed at a recent Clinical Translational Radiotherapy Group (CTRad) workshop.

Original languageEnglish
Pages (from-to)720-725
Number of pages6
JournalClinical oncology (Royal College of Radiologists (Great Britain))
Volume28
Issue number11
Early online date31 Aug 2016
DOIs
Publication statusPublished - Nov 2016

Keywords

  • Lung Cancer
  • Systemic Therapy
  • DNA Damaging Agents
  • Radiotherapy
  • Chemoradiotherapy

Fingerprint Dive into the research topics of 'The Challenges Faced in Developing Novel Drug Radiation Combinations in Non-small Cell Lung Cancer'. Together they form a unique fingerprint.

Cite this